EIP Pharma, Inc. — Form D
EIP Pharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-20. The offering totals $810K, of which $810K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-20
- Form: D
- Accession: 0001736525-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $810K
- Amount sold: $810K
- Investors: 2
- Date of first sale: 2023-07-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-487497
Issuer
- Name: EIP Pharma, Inc.
- CIK: 0001736525
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Phone: 617-744-4400
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| JOHN ALAM | Director | BOSTON, MA |
| SYLVIE GREGOIRE | Director | Boston, MA |
| JEFF POULTON | Director | Boston, MA |
| MARWAN SABBAGH | Director | Boston, MA |
| FRANK ZAVRL | Director | BOSTON, MA |
| JOHN ALAM | Executive Officer | BOSTON, MA |
| KELLY BLACKBURN | Executive Officer | BOSTON, MA |
| WILLIAM TURNER | Executive Officer | Boston, MA |
| SYLVIE GREGOIRE | Executive Officer | Boston, MA |
| Tatjana May | Director | Boston, MA |
| Noel Donnelly | Executive Officer | Boston, MA |
Other filings by this issuer (5)
More